2016 Form 10-K Financial Statement

#000143774917005089 Filed on March 22, 2017

View on sec.gov

Income Statement

Concept 2016 2015 Q4 2015
Revenue $23.75M $5.440M $21.40M
YoY Change 11.01% 13.1% 29.99%
Cost Of Revenue $8.230M $1.790M $6.494M
YoY Change 26.73% 84.54% 57.95%
Gross Profit $15.52M $3.650M $14.90M
YoY Change 4.16% -4.95% 20.69%
Gross Profit Margin 65.35% 67.1% 69.65%
Selling, General & Admin $8.344M $3.290M $8.999M
YoY Change -7.28% -25.4% 44.67%
% of Gross Profit 53.75% 90.14% 60.38%
Research & Development $4.024M $1.040M $4.629M
YoY Change -13.08% 225.0% 86.26%
% of Gross Profit 25.92% 28.49% 31.06%
Depreciation & Amortization $761.3K $270.0K $1.339M
YoY Change -43.13% -37.21% 1.29%
% of Gross Profit 4.9% 7.4% 8.98%
Operating Expenses $18.17M $4.320M $20.99M
YoY Change -13.41% -8.67% 34.8%
Operating Profit -$2.652M -$670.0K -$6.086M
YoY Change -56.43% -24.72% 88.91%
Interest Expense -$1.200M -$60.00K -$178.3K
YoY Change 572.95% 100.0% 462.17%
% of Operating Profit
Other Income/Expense, Net -$1.200M -$178.3K
YoY Change 572.94% 462.13%
Pretax Income -$3.852M -$730.0K -$6.264M
YoY Change -38.51% -20.65% 92.55%
Income Tax
% Of Pretax Income
Net Earnings -$3.852M -$730.0K -$6.264M
YoY Change -38.51% -20.65% 92.55%
Net Earnings / Revenue -16.21% -13.42% -29.28%
Basic Earnings Per Share -$0.06 -$0.10
Diluted Earnings Per Share -$0.06 -$11.22K -$0.10
COMMON SHARES
Basic Shares Outstanding 65.13M 65.06M 63.66M
Diluted Shares Outstanding 65.13M 63.66M

Balance Sheet

Concept 2016 2015 Q4 2015
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.680M $910.0K $908.1K
YoY Change 85.02% -19.47% -19.68%
Cash & Equivalents $908.1K
Short-Term Investments
Other Short-Term Assets $448.2K $240.0K $239.9K
YoY Change 86.81% 20.0% 17.45%
Inventory
Prepaid Expenses
Receivables $2.230M $1.833M $1.833M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $4.358M $2.981M $2.981M
YoY Change 46.19% -3.35% -3.35%
LONG-TERM ASSETS
Property, Plant & Equipment $2.933M $1.957M $1.957M
YoY Change 49.89% 37.34% 37.34%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $102.6K $124.9K $161.4K
YoY Change -36.47% -6.1% -5.45%
Total Long-Term Assets $3.036M $2.082M $2.118M
YoY Change 43.31% 10.04% 11.97%
TOTAL ASSETS
Total Short-Term Assets $4.358M $2.981M $2.981M
Total Long-Term Assets $3.036M $2.082M $2.118M
Total Assets $7.394M $5.063M $5.099M
YoY Change 44.99% 1.74% 2.47%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.639M $2.240M
YoY Change 86.67%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $506.9K $0.00 $0.00
YoY Change
Long-Term Debt Due $2.039M $4.640M $4.635M
YoY Change -56.01%
Total Short-Term Liabilities $5.238M $6.846M $6.882M
YoY Change -23.89% 385.86% 388.46%
LONG-TERM LIABILITIES
Long-Term Debt $4.588M $0.00 $0.00
YoY Change -100.0% -100.0%
Other Long-Term Liabilities $1.488M
YoY Change
Total Long-Term Liabilities $6.076M $0.00 $0.00
YoY Change -100.0% -100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $5.238M $6.846M $6.882M
Total Long-Term Liabilities $6.076M $0.00 $0.00
Total Liabilities $11.31M $6.846M $6.882M
YoY Change 64.4% 58.87% 59.72%
SHAREHOLDERS EQUITY
Retained Earnings -$25.27M
YoY Change 32.96%
Common Stock $65.07K
YoY Change 3.59%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$3.920M -$1.783M -$1.783M
YoY Change
Total Liabilities & Shareholders Equity $7.394M $5.063M $5.099M
YoY Change 44.99% 1.74% 2.47%

Cashflow Statement

Concept 2016 2015 Q4 2015
OPERATING ACTIVITIES
Net Income -$3.852M -$730.0K -$6.264M
YoY Change -38.51% -20.65% 92.55%
Depreciation, Depletion And Amortization $761.3K $270.0K $1.339M
YoY Change -43.13% -37.21% 1.29%
Cash From Operating Activities $320.9K $450.0K -$2.088M
YoY Change -115.37% -188.24% -20.36%
INVESTING ACTIVITIES
Capital Expenditures $20.21K $0.00 $152.1K
YoY Change -86.72% -100.0% -74.58%
Acquisitions
YoY Change
Other Investing Activities -$1.991M -$480.0K -$1.426M
YoY Change 39.62% 182.35% 96.73%
Cash From Investing Activities -$2.011M -$480.0K -$1.578M
YoY Change 27.44% 9.09% 19.26%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00 $1.852M
YoY Change -100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 2.518M 420.0K 3.454M
YoY Change -27.11% -40.85% -12.1%
NET CHANGE
Cash From Operating Activities 320.9K 450.0K -2.088M
Cash From Investing Activities -2.011M -480.0K -1.578M
Cash From Financing Activities 2.518M 420.0K 3.454M
Net Change In Cash 827.7K 390.0K -211.9K
YoY Change -490.67% -262.5% 1251.43%
FREE CASH FLOW
Cash From Operating Activities $320.9K $450.0K -$2.088M
Capital Expenditures $20.21K $0.00 $152.1K
Free Cash Flow $300.7K $450.0K -$2.240M
YoY Change -113.43% -287.5% -30.44%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2015 aclz Adjustments To Additional Paid In Capital Sharebased Compensation Warrants Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationWarrantsRequisiteServicePeriodRecognition
1136371
CY2015Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1854351
CY2016Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-77329
CY2015Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-21680
CY2016Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
25211737
CY2016 aclz Adjustments To Additional Paid In Capital Sharebased Compensation Warrants Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationWarrantsRequisiteServicePeriodRecognition
806334
CY2016 aclz Cash Exercise Of Options
CashExerciseOfOptions
11457
CY2016 aclz Cashless Exercise Of Options
CashlessExerciseOfOptions
50000
CY2015Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
23440366
CY2015 aclz Cashless Exercise Of Options
CashlessExerciseOfOptions
143541
CY2015 aclz Common Stock And Warrants Issued During Period Value
CommonStockAndWarrantsIssuedDuringPeriodValue
2145000
CY2016Q4 aclz Common Stock Issued And Outstanding Percentage Decrease
CommonStockIssuedAndOutstandingPercentageDecrease
0.03
CY2016 aclz Fair Value Of Options And Warrants
FairValueOfOptionsAndWarrants
1268097
CY2015 aclz Fair Value Of Options And Warrants
FairValueOfOptionsAndWarrants
2068397
CY2016 aclz Fair Value Of Warrants Issued In Connection With Line Of Credit
FairValueOfWarrantsIssuedInConnectionWithLineOfCredit
501620
CY2015 aclz Fair Value Of Warrants Issued In Connection With Line Of Credit
FairValueOfWarrantsIssuedInConnectionWithLineOfCredit
37289
CY2016 aclz Other Finance Fees
OtherFinanceFees
483583
CY2015 aclz Other Finance Fees
OtherFinanceFees
17105
CY2015 aclz Proceeds From Issuance Of Common Stock And Warrants
ProceedsFromIssuanceOfCommonStockAndWarrants
1700000
CY2015 aclz Proceeds From Stock Options And Warrant Exercises
ProceedsFromStockOptionsAndWarrantExercises
9587
CY2016 aclz Proceeds From Stock Options And Warrant Exercises
ProceedsFromStockOptionsAndWarrantExercises
CY2016 aclz Repayment Of Line Of Credit Noncash Investing And Financing Activities
RepaymentOfLineOfCreditNoncashInvestingAndFinancingActivities
4572223
CY2015 aclz Repayment Of Line Of Credit Noncash Investing And Financing Activities
RepaymentOfLineOfCreditNoncashInvestingAndFinancingActivities
CY2016 aclz Repayment Of Loan Noncash Investing And Financing Activities
RepaymentOfLoanNoncashInvestingAndFinancingActivities
25000
CY2015 aclz Repayment Of Loan Noncash Investing And Financing Activities
RepaymentOfLoanNoncashInvestingAndFinancingActivities
CY2016 aclz Stock Cancelled
StockCancelled
1900
CY2015 aclz Stock Cancelled
StockCancelled
CY2015 aclz Stock Issued During Period Shares Stock Options Exercised Cash
StockIssuedDuringPeriodSharesStockOptionsExercisedCash
11457
CY2016 aclz Stock Issued During Period Shares Stock Options Exercised Noncash
StockIssuedDuringPeriodSharesStockOptionsExercisedNoncash
5714
CY2015 aclz Stock Issued During Period Shares Stock Options Exercised Noncash
StockIssuedDuringPeriodSharesStockOptionsExercisedNoncash
96316
CY2015 aclz Stock Issued During Period Value Stock Options Exercised Noncash
StockIssuedDuringPeriodValueStockOptionsExercisedNoncash
CY2015 aclz Stockissuedduringperiodvaluestockoptionsexercisedcash
Stockissuedduringperiodvaluestockoptionsexercisedcash
9587
CY2016 aclz Weighted Average Number Of Diluted Shares Outstanding Discontinued Operations
WeightedAverageNumberOfDilutedSharesOutstandingDiscontinuedOperations
65129153
CY2015 aclz Weighted Average Number Of Diluted Shares Outstanding Discontinued Operations
WeightedAverageNumberOfDilutedSharesOutstandingDiscontinuedOperations
63659639
CY2016 aclz Weightedaverage Antidilutive Securities Excluded From Computation Of Earnings Per Share Amountloss
WeightedaverageAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmountloss
18432724
CY2015 aclz Weightedaverage Antidilutive Securities Excluded From Computation Of Earnings Per Share Amountloss
WeightedaverageAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmountloss
20347989
CY2016Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
2639008
CY2015Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
2236750
CY2016Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2229610
CY2015Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1833007
CY2016Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2585072
CY2015 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
932026
CY2016 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
461764
CY2015 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
143169
CY2015 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
37289
CY2016 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
501620
CY2016 us-gaap Advertising Cost Policy Expensed Advertising Cost
AdvertisingCostPolicyExpensedAdvertisingCost
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; text-decoration: underline;">Advertising</div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The Company expenses advertising costs as incurred.&nbsp;</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">2016</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">2015</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px">&nbsp;</td> </tr> <tr> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 70%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Advertising expense</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">552,924</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">415,900</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> </table> </div></div></div></div></div></div></div></div></div></div></div></div>
CY2016 us-gaap Advertising Expense
AdvertisingExpense
552924
CY2015 us-gaap Advertising Expense
AdvertisingExpense
415900
CY2016Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
349535
CY2015Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
395147
CY2016 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
239707
CY2015 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
41981
CY2016 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
761833
CY2015 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
730481
CY2016Q4 us-gaap Assets
Assets
7393624
CY2015Q4 us-gaap Assets
Assets
5062769
CY2016Q4 us-gaap Assets Current
AssetsCurrent
4357924
CY2015Q4 us-gaap Assets Current
AssetsCurrent
2981023
CY2016Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
2785000
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
908095
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1130667
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1680127
CY2016 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
772032
CY2015 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-222572
CY2016Q4 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000
CY2015Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
1.32
CY2015Q4 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
1287000
CY2016Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2015Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2016Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2015Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2016Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
63415254
CY2015Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
65069327
CY2016Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
63415254
CY2015Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
65069327
CY2016Q4 us-gaap Common Stock Value
CommonStockValue
63414
CY2015Q4 us-gaap Common Stock Value
CommonStockValue
65068
CY2016 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-3907233
CY2015 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-6274747
CY2016 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; text-decoration: underline;">Concentration of Credit Risks</div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The Company is subject to concentrations of credit risk primarily from cash, cash equivalents and accounts receivable.</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The Company&#x2019;s cash and cash equivalents accounts are held at a financial institution and are insured by the Federal Deposit Insurance Corporation, or the FDIC, up to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$250,000.</div> During <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015,</div> the Company has reached bank balances exceeding the FDIC insurance limit. To reduce its risk associated with the failure of such financial institutions, the Company periodically evaluates the credit quality of financial institutions in which it holds deposits.</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;&nbsp;</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The Company's accounts receivable are due from customers, generally located in the United States, Europe, Asia, and Canada. None of the Company&#x2019;s customers accounted for more than <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10%</div> of its accounts receivable at <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015.</div>&nbsp;The Company does not require any collateral from its customers.</div></div></div></div></div></div></div></div></div></div></div></div></div>
CY2016Q4 us-gaap Contractual Obligation Due In Next Twelve Months
ContractualObligationDueInNextTwelveMonths
1461522
CY2016Q4 us-gaap Contractual Obligation Due In Second Year
ContractualObligationDueInSecondYear
1505378
CY2016 us-gaap Cost Of Revenue
CostOfRevenue
8230420
CY2015 us-gaap Cost Of Revenue
CostOfRevenue
6494339
CY2016Q4 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
429769
CY2015Q4 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
0
CY2016Q4 us-gaap Deferred Revenue
DeferredRevenue
53450
CY2015Q4 us-gaap Deferred Revenue
DeferredRevenue
10436
CY2016Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
53450
CY2015Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
10436
CY2016Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
9276271
CY2015Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
7301784
CY2016Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
CY2015Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0
CY2016Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
6017984
CY2015Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
5573184
CY2016Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
1080361
CY2015Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
499898
CY2016Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
2177926
CY2015Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
1228702
CY2016Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
9276271
CY2015Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
7301784
CY2016 us-gaap Depreciation
Depreciation
273302
CY2015 us-gaap Depreciation
Depreciation
297068
CY2016 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
761276
CY2015 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1338667
CY2016 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.06
CY2015 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.10
CY2016 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.06
CY2015 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.10
CY2016 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-55649
CY2015 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-10709
CY2016 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.061
CY2015 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2016 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.34
CY2015 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.34
CY2016 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.4
CY2015 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.381
CY2016 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
-0.001
CY2015 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
0.003
CY2016 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0
CY2015 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.038
CY2016Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
492879
CY2016 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P3Y270D
CY2016 us-gaap Fair Value Assumptions Expected Dividend Rate
FairValueAssumptionsExpectedDividendRate
0
CY2015 us-gaap Fair Value Assumptions Expected Dividend Rate
FairValueAssumptionsExpectedDividendRate
0
CY2016 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
290
CY2015 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-3501
CY2016 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
-2200000
CY2015 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
CY2016 us-gaap Gross Profit
GrossProfit
15523026
CY2015 us-gaap Gross Profit
GrossProfit
14902613
CY2016Q4 us-gaap Income Tax Examination Penalties And Interest Accrued
IncomeTaxExaminationPenaltiesAndInterestAccrued
0
CY2016 us-gaap Interest Paid
InterestPaid
492581
CY2015 us-gaap Interest Paid
InterestPaid
263077
CY2016 us-gaap Investment Income Interest
InvestmentIncomeInterest
20833
CY2015 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1030754
CY2016 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
350991
CY2015 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
266475
CY2016 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
43014
CY2015 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-196039
CY2016 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-22024
CY2015 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-8106
CY2016 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
158266
CY2015 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
35653
CY2016 us-gaap Increase Decrease In Restricted Cash For Operating Activities
IncreaseDecreaseInRestrictedCashForOperatingActivities
50000
CY2015 us-gaap Increase Decrease In Restricted Cash For Operating Activities
IncreaseDecreaseInRestrictedCashForOperatingActivities
CY2016 us-gaap Interest Expense Debt
InterestExpenseDebt
1220840
CY2015 us-gaap Interest Expense Debt
InterestExpenseDebt
266884
CY2016 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
492851
CY2015 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
207798
CY2016 us-gaap Income Taxes Paid
IncomeTaxesPaid
0
CY2015 us-gaap Income Taxes Paid
IncomeTaxesPaid
0
CY2016 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-455242
CY2015 us-gaap Investment Income Interest
InvestmentIncomeInterest
88561
CY2016Q4 us-gaap Liabilities
Liabilities
11313998
CY2015Q4 us-gaap Liabilities
Liabilities
6845627
CY2016Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
7393624
CY2015Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5062769
CY2016Q4 us-gaap Liabilities Current
LiabilitiesCurrent
5238271
CY2015Q4 us-gaap Liabilities Current
LiabilitiesCurrent
6845627
CY2014Q3 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
6000000
CY2014Q1 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
3000000
CY2016Q1 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
5135000
CY2016Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
2038946
CY2015Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
4598441
CY2016Q4 us-gaap Litigation Reserve
LitigationReserve
2700000
CY2016Q4 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
4588227
CY2015Q4 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
CY2016 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2517592
CY2015 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3453780
CY2016 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2010823
CY2015 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1577878
CY2016 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
320912
CY2015 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2087765
CY2016 us-gaap Net Income Loss
NetIncomeLoss
-3851584
CY2015 us-gaap Net Income Loss
NetIncomeLoss
-6264038
CY2016 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1200007
CY2015 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-178323
CY2016 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2015 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2016 us-gaap Operating Expenses
OperatingExpenses
18174603
CY2015 us-gaap Operating Expenses
OperatingExpenses
20988328
CY2016 us-gaap Operating Income Loss
OperatingIncomeLoss
-2651577
CY2015 us-gaap Operating Income Loss
OperatingIncomeLoss
-6085715
CY2016Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
323902
CY2016Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
42682
CY2016Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
15600000
CY2016Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
102574
CY2015Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
124882
CY2016 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-55649
CY2015 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-10709
CY2016 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-55649
CY2015 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-10709
CY2016Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1487500
CY2015Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
CY2016 us-gaap Other Noncash Expense
OtherNoncashExpense
424920
CY2015 us-gaap Other Noncash Expense
OtherNoncashExpense
CY2016Q4 us-gaap Other Short Term Borrowings
OtherShortTermBorrowings
506867
CY2015Q4 us-gaap Other Short Term Borrowings
OtherShortTermBorrowings
CY2016 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
129678
CY2015 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
CY2016 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
CY2015 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
143169
CY2016 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
20206
CY2015 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
152126
CY2016 us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
1997759
CY2015 us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
1436842
CY2016Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
398187
CY2015Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
239921
CY2016 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; text-decoration: underline;">Reclassification</div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The balance sheet, and related footnotes, for the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015</div> has been reclassified to reflect the adoption of ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">03</div> which changes the presentation of debt issuance costs in financial statements and requires an entity to present such costs in the balance sheet as a direct deduction from the related debt liability rather than as an asset.</div></div></div></div></div></div></div></div></div></div></div></div></div>
CY2016 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
CY2015 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1852362
CY2016 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
3003105
CY2015 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
1735000
CY2016 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
7142
CY2015 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
11090
CY2016 us-gaap Profit Loss
ProfitLoss
-3851584
CY2015 us-gaap Profit Loss
ProfitLoss
-6264038
CY2016Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
5518198
CY2015Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3811215
CY2016Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2933126
CY2015Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1956864
CY2016 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-45612
CY2015 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
183034
CY2016Q1 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
62777
CY2016 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
355835
CY2015 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
CY2016 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4023879
CY2015 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4629419
CY2016Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
50000
CY2015Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
CY2016Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-29118196
CY2015Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-25266612
CY2016 us-gaap Revenues
Revenues
23753446
CY2015 us-gaap Revenues
Revenues
21396952
CY2015Q4 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
1
CY2016 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
1
CY2015 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
1.14
CY2016 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.50
CY2015 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
8998512
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.7
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
22500000
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
10887623
CY2016 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
3606875
CY2015 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
7360397
CY2016 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
8343849
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
0.33
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
1503338
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
2485000
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
840000
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
2070000
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.19
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.53
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
14573511
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
127500
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
1760425
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
14408336
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
13590000
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
13125000
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.50
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.48
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.39
CY2015 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.63
CY2016 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.31
CY2015 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
0.79
CY2016 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
CY2015 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P4Y
CY2016Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
2028169
CY2016 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P4Y105D
CY2014 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y295D
CY2015 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y302D
CY2016 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y36D
CY2016 us-gaap Stock Issued1
StockIssued1
246
CY2015 us-gaap Stock Issued1
StockIssued1
CY2015 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
2145000
CY2015 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
154998
CY2016 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
50000
CY2015 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1852362
CY2016 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
-3920374
CY2015Q4 us-gaap Stockholders Equity
StockholdersEquity
-1782858
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
667423
CY2016 us-gaap Tangible Asset Impairment Charges
TangibleAssetImpairmentCharges
273859
CY2015 us-gaap Tangible Asset Impairment Charges
TangibleAssetImpairmentCharges
CY2016 us-gaap Use Of Estimates
UseOfEstimates
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; text-decoration: underline;">Use of Estimates</div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reporting amounts of revenues and expenses during the reported period. Actual results will differ from those estimates. Included in these estimates are assumptions about collection of accounts receivable, useful life of fixed assets and intangible assets, and assumptions used in Black-Scholes-Merton, or BSM, valuation methods, such as expected volatility, risk-free interest rate, and expected dividend rate.</div></div></div></div></div></div></div></div></div></div></div></div></div>
CY2016 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
65129153
CY2015 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
63659639
CY2016 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
65129153
CY2015 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
63659639
CY2016 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
65129153
CY2015 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
63659639

Files In Submission

Name View Source Status
0001437749-17-005089-index-headers.html Edgar Link pending
0001437749-17-005089-index.html Edgar Link pending
0001437749-17-005089.txt Edgar Link pending
0001437749-17-005089-xbrl.zip Edgar Link pending
aclz-20161231.xml Edgar Link completed
aclz-20161231.xsd Edgar Link pending
aclz-20161231_cal.xml Edgar Link unprocessable
aclz-20161231_def.xml Edgar Link unprocessable
aclz-20161231_lab.xml Edgar Link unprocessable
aclz-20161231_pre.xml Edgar Link unprocessable
aclz20161231_10k.htm Edgar Link pending
ex23-1.htm Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending